Fulgent Genetics
FLGT
196 hedge funds and large institutions have $414M invested in Fulgent Genetics in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 73 reducing their positions, and 31 closing their positions.
1,719% more call options, than puts
Call options by funds: $67.6M | Put options by funds: $3.72M
9% more capital invested
Capital invested by funds: $380M → $414M (+$33M)
0.73% more ownership
Funds ownership: 47.54% → 48.27% (+0.73%)
10% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 31
2% less funds holding
Funds holding: 201 → 196 (-5)
30% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 73
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.92M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.93M |
| 3 |
BlackRock
New York
|
+$4.18M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.98M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$19.3M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$5.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.88M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.59M |
| 5 |
Bank of New York Mellon
New York
|
-$1.55M |
FLGT Hedge Fund Activity: Q4 2023 in Review
196 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2023, worth a combined $414M — up 8.7% from $380M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of FLGT and 28 opened new positions — a net loss of 3 holders — while 73 trimmed existing stakes and 51 added.
The largest buyer was Millennium Management, adding an estimated $8.92M. The largest seller was Divisadero Street Capital Management, cutting an estimated $19.3M.
- 196 institutional investors held Fulgent Genetics (FLGT) as of Q4 2023, down from 201 in Q3 2023.
- Funds reported $414M of Fulgent Genetics stock for Q4 2023, up 8.7% quarter-over-quarter.
- 28 funds opened new Fulgent Genetics positions in Q4 2023 and 31 closed out, a net change of -3 holders.
- The largest Fulgent Genetics buyer in Q4 2023 was Millennium Management, an estimated $8.92M added.
- The largest Fulgent Genetics seller in Q4 2023 was Divisadero Street Capital Management, an estimated $19.3M sold.
Based on aggregated 13F filings for Q4 2023.